Dergiler / Turkish Journal of Pediatrics / 2021 / Cilt: 63 - Sayı: 6

Cerebral sinovenous thrombosis in children: clinical presentation, locations, and acquired and inherited prothrombotic risk factors

Sayfa
1028–1037
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The risk of acute complications and long-term sequelae can be substantially reduced if diagnosed early and initiated with appropriate treatment at the early stages.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Cerebral sinovenous thrombosis (CSVT) in children is a rare and life-threatening cerebrovascular disease.
📊
Temel Bulgular & Veri:The medical records of pediatric CSVT patients treated between January 2011 and September 2018 were analyzed retrospectively.
💡
Sonuç & Katkı:The risk of acute complications and long-term sequelae can be substantially reduced if diagnosed early and initiated with appropriate treatment at the early stages.
🔬Tür:Araştırma Makalesi
📍Kapsam:2011 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

Background. Cerebral sinovenous thrombosis (CSVT) in children is a rare and life-threatening cerebrovascular disease. Hence, we evaluated its clinical presentations, inherited and acquired prothrombotic risk factors along with the accompanying diseases, the thrombosis locations as well as the outcomes of anticoagulant therapy in children with CSVT. Methods. The medical records of pediatric CSVT patients treated between January 2011 and September 2018 were analyzed retrospectively. Results. The study included 29 children, 15 boys (51.7%) and 14 girls (48.3%), with the median age being 11 years (range:3 days-17 years). The most commonly presented complaint in neonates was seizures and in the non-neonatal age groups was a headache. Also, at least one acquired and/or inherited thrombophilic risk factor was identified in 89.7% of the patients. The most commonly acquired prothrombotic risk factors along with the accompanying diseases included infections, central venous catheter, and dehydration, while the most commonly inherited thrombophilic risk factors included heterozygous factor-V Leiden mutation and elevated lipoprotein (a). The most common thrombosis location was found to be the transverse sinus. Also, none of the patients died due to the thrombotic episode. Complications included epilepsy in five patients, hydrocephalus in one patient, and intracranial hypertension in another patient. Conclusions. Clinicians need to be well aware of the inherited and acquired prothrombotic risk factors in CSVT. It should also be kept in mind that at-risk patients may also present with nonspecific signs and symptoms with no apparent neurological manifestation. The risk of acute complications and long-term sequelae can be substantially reduced if diagnosed early and initiated with appropriate treatment at the early stages.

🔖

Bu Makaleye Atıf Yap

KAR, Y. D., ÖZDEMİR, Z. C., ÇARMAN, K. B., YARAR, C., TEKİN, N., BÖR, Ö. (2021). Cerebral sinovenous thrombosis in children: clinical presentation, locations, and acquired and inherited prothrombotic risk factors. Turkish Journal of Pediatrics, Cilt: 63 - Sayı: 6, 1028–1037. https://ajindex.com/articles/411753

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. . Carducci C, Colafati GS, Figà-Talamanca L, et al. Cerebral sinovenous thrombosis (CSVT) in children: what the pediatric radiologists need to know. Radiol Med 2016
  2. https://doi.org/10.1007/ s11547-016-0630-9 2. Ritchey Z, Hollatz AL, Weitzenkamp D, et al. Pediatric cortical vein thrombosis: frequency and association with venous infarction. Stroke 2016
  3. https://doi.org/10.1161/STROKEAHA.115.011291 3. Ichord RN, Benedict SL, Chan AK, Kirkham FJ, Nowak-Göttl U
  4. International Paediatric Stroke Study Group. Paediatric cerebral sinovenous thrombosis: findings of the International Paediatric Stroke Study. Arch Dis Child 2015
  5. https://doi.org/10.1136/archdischild-2014-306382 4. Bektaş Ö, Teber S, Akar N, et al. Cerebral sinovenous thrombosis in children and neonates: clinical experience, laboratory, treatment, and outcome. Clin Appl Thromb Hemost 2015
  6. https:// doi.org/10.1177/1076029614523491 5. Ozcan A, Canpolat M, Doganay S, et al. Cerebral sinus venous thrombosis and prothrombotic risk factors in children: a single- center experience from Turkey. J Pediatr Hematol Oncol 2018
  7. e369-e372. https://doi.org/10.1097/MPH.0000000000001149 6. Ichord R. Cerebral sinovenous thrombosis. Front Pediatr 2017
  8. https://doi.org/10.3389/ fped.2017.00163 7. Ferriero DM, Fullerton HJ, Bernard TJ, et al
  9. American Heart Association Stroke Council and Council on Cardiovascular and Stroke Nursing. Management of stroke in neonates and children: a scientific statement from the American Heart Association/American Stroke Association. Stroke 2019
  10. e51-e96. https:// doi.org/10.1161/STR.0000000000000183 8. Acharya SS, Sarangi SN. Disorders of coagulation. In: Lanzkowsky P, Lipton JM, Fish JD (eds). Lanzkowsky’s Manual of Pediatric Hematology and Oncology (6th ed). New York: Academic Press, 2016: 279-333. https://doi.org/10.1016/B978-0-12-801368- 7.00015-6 9. Yang JY, Chan AK. Pediatric thrombophilia. Pediatr Clin North Am 2013
  11. https://doi. org/10.1016/j.pcl.2013.09.00 10. Monagle P, Chan AKC, Goldenberg NA, et al. Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012
  12. 141(Suppl 2): e737S-e801S. https://doi.org/10.1378/chest.11-2308 11. Heller C, Heinecke A, Junker R, et al
  13. Childhood Stroke Study Group. Cerebral venous thrombosis in children: a multifactorial